Angiotensin-converting enzyme gene polymorphism in children with idiopathic nephrotic syndrome. 2006

I-Jung Tsai, and Yao-Hsu Yang, and Yen-Hung Lin, and Vin-Cent Wu, and Yong-Kwei Tsau, and Fon-Jou Hsieh
Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

OBJECTIVE To investigate the genetic polymorphism of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) in children with idiopathic nephrotic syndrome (INS), as well as its relationship with patient's clinical response to steroid therapy. METHODS Fifty-nine patients with INS were recruited and divided into 2 groups according to their clinical response to steroids: steroid-sensitive (SS) with 19 patients and non-SS with 40 patients, which was further divided into steroid-dependent (SD) and steroid-resistant (SR) groups with 35 and 5 patients, respectively. Seventy-nine children without previous renal diseases and negative proteinuria were enrolled as a control group. The genotypes for ACE I/D polymorphism, including DD, ID, and II, were analyzed. RESULTS The distribution of ACE DD, ID, and II genotypes in INS patients were 52.5, 10.2 and 37.3%, respectively; the corresponding numbers for the control group were 2.5, 25.3 and 72.2%, respectively. Patients with INS had a significantly higher percentage of DD genotype (p <0.001) than the control group. This higher incidence of the DD genotype was observed in both the SS and non-SS groups. A higher percentage of the DD genotype in the non-SS group and in the SD group as compared to the SS group (both p < 0.05) was also noted. CONCLUSIONS Our data shows that INS is associated with a higher incidence of the DD genotype, especially in non-SS patients. This finding suggests that the DD genotype may be a risk factor for INS and play a role in the clinical response to steroids.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

I-Jung Tsai, and Yao-Hsu Yang, and Yen-Hung Lin, and Vin-Cent Wu, and Yong-Kwei Tsau, and Fon-Jou Hsieh
August 2017, Fetal and pediatric pathology,
I-Jung Tsai, and Yao-Hsu Yang, and Yen-Hung Lin, and Vin-Cent Wu, and Yong-Kwei Tsau, and Fon-Jou Hsieh
June 2001, Scandinavian journal of urology and nephrology,
I-Jung Tsai, and Yao-Hsu Yang, and Yen-Hung Lin, and Vin-Cent Wu, and Yong-Kwei Tsau, and Fon-Jou Hsieh
October 2005, Indian journal of medical sciences,
I-Jung Tsai, and Yao-Hsu Yang, and Yen-Hung Lin, and Vin-Cent Wu, and Yong-Kwei Tsau, and Fon-Jou Hsieh
December 2011, Journal of the renin-angiotensin-aldosterone system : JRAAS,
I-Jung Tsai, and Yao-Hsu Yang, and Yen-Hung Lin, and Vin-Cent Wu, and Yong-Kwei Tsau, and Fon-Jou Hsieh
June 2010, Journal of the renin-angiotensin-aldosterone system : JRAAS,
I-Jung Tsai, and Yao-Hsu Yang, and Yen-Hung Lin, and Vin-Cent Wu, and Yong-Kwei Tsau, and Fon-Jou Hsieh
January 2012, Renal failure,
I-Jung Tsai, and Yao-Hsu Yang, and Yen-Hung Lin, and Vin-Cent Wu, and Yong-Kwei Tsau, and Fon-Jou Hsieh
June 2019, Journal of biomedical research,
I-Jung Tsai, and Yao-Hsu Yang, and Yen-Hung Lin, and Vin-Cent Wu, and Yong-Kwei Tsau, and Fon-Jou Hsieh
December 2006, Nephrology (Carlton, Vic.),
I-Jung Tsai, and Yao-Hsu Yang, and Yen-Hung Lin, and Vin-Cent Wu, and Yong-Kwei Tsau, and Fon-Jou Hsieh
January 2011, Indian journal of nephrology,
I-Jung Tsai, and Yao-Hsu Yang, and Yen-Hung Lin, and Vin-Cent Wu, and Yong-Kwei Tsau, and Fon-Jou Hsieh
January 1997, Nephron,
Copied contents to your clipboard!